Comparative outcomes of systemic therapy vs. locoregional therapies in hepatocellular carcinoma with portal vein thrombosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to advance his research on viral insulins into the understanding ...

Boston College Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to study viral insulins and mechanisms related to ...

Dr Isabella Cooper is a biochemistry medical pathology scientist, and ketogenic specialist whose research focuses on ageing biology, hyperinsulinaemia, ketogenic science, and chronic diseases ...

In a recent study published in the journal Scientific Reports, researchers analyzed whole-exome genetic data from more than 2,000 Ashkenazi Jewish centenarians and their relatives to investigate ...

FOXO3a predicts for survival and its phosphorylated form is downregulated following mTOR or MEK inhibitor therapy in Hepatocellular Carcinoma Performance status 0 (n=42) (vs. PS 2) 0.19 0.05 - 0.72 ...

Levels of the hormone increase with disease severity, a new study has found. Plasma levels of insulin-like growth factor 1 (IGF-1) could give clinicians a better understanding of whether a patient ...

Researchers from Osaka University find that infection with SARS-CoV-2 activates the IRF1 gene and impairs insulin/IGF signaling in the lung, liver, adipose tissue, and pancreatic cells Osaka, Japan - ...

In the Altindis Lab, we adopt an interdisciplinary approach to address two complex and vital questions. Our primary objectives encompass: (a) characterizing the effects of viral insulin/IGF-1-like ...

Nutrition is increasingly recognized as a modifiable factor influencing the risk, progression, and survivorship of cancers that disproportionately affect ...